221 related articles for article (PubMed ID: 32310045)
1. Drug-induced Bile Duct Injury - A Short Review.
Dobreva I; Karagyozov P
Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced bile duct injury.
Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
[TBL] [Abstract][Full Text] [Related]
3. Xenobiotic-induced liver injury and fibrosis.
Österreicher CH; Trauner M
Expert Opin Drug Metab Toxicol; 2012 May; 8(5):571-80. PubMed ID: 22452290
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
5. [Drug-induced bile duct injury: progress and challenges].
Li DL
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
[TBL] [Abstract][Full Text] [Related]
6. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
Pollheimer MJ; Fickert P; Stieger B
Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
Nakanishi Y; Saxena R
Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine-induced vanishing bile duct syndrome in a child.
Bhayana H; Appasani S; Thapa BR; Das A; Singh K
J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):e147-8. PubMed ID: 22008955
[No Abstract] [Full Text] [Related]
9. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
[TBL] [Abstract][Full Text] [Related]
10. Meropenem-induced vanishing bile duct syndrome.
Schumaker AL; Okulicz JF
Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome.
Shionoya K; Kobayashi M; Kako M; Masuda S; Makazu M; Koizumi K
Intern Med; 2024 Jun; 63(12):1719-1723. PubMed ID: 37952956
[TBL] [Abstract][Full Text] [Related]
12. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
13. Animal models of cholestasis: An update on inflammatory cholangiopathies.
Mariotti V; Cadamuro M; Spirli C; Fiorotto R; Strazzabosco M; Fabris L
Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):954-964. PubMed ID: 30398152
[TBL] [Abstract][Full Text] [Related]
14. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis: review for radiologists.
Morgan MA; Khot R; Sundaram KM; Ludwig DR; Nair RT; Mittal PK; Ganeshan DM; Venkatesh SK
Abdom Radiol (NY); 2023 Jan; 48(1):136-150. PubMed ID: 36063181
[TBL] [Abstract][Full Text] [Related]
16. [Secondary drug-induced cholestasis with bile duct involvement].
Horsmans Y; Harvengt C
Acta Gastroenterol Belg; 1991; 54(1):27-33. PubMed ID: 2058347
[TBL] [Abstract][Full Text] [Related]
17. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
18. Vanishing bile duct syndrome in drug-induced liver disease.
Desmet VJ
J Hepatol; 1997; 26 Suppl 1():31-5. PubMed ID: 9138126
[No Abstract] [Full Text] [Related]
19. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
Xie W; Wang Q; Gao Y; Pan CQ
BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
[TBL] [Abstract][Full Text] [Related]
20. Primary sclerosing cholangitis, a vanishing bile duct disease.
van Berge Henegouwen GP
Neth J Med; 1987 Aug; 31(1-2):27-35. PubMed ID: 3658059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
